A novel multimodality endoscopic device for colonic submucosal dissection using a combination of bipolar radiofrequency and microwave modalities
- Submitting institution
-
Bangor University / Prifysgol Bangor
- Unit of assessment
- 12 - Engineering
- Output identifier
- UoA12_59
- Type
- D - Journal article
- DOI
-
10.1055/s-0042-101344
- Title of journal
- Endoscopy
- Article number
- -
- First page
- 271-276
- Volume
- 48
- Issue
- 03
- ISSN
- 0013-726X
- Open access status
- Out of scope for open access requirements
- Month of publication
- February
- Year of publication
- 2016
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
4
- Research group(s)
-
-
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- Clinical paper resulting from Chris Hancock’s research at Bangor and spinout Creo Medical describing new RF/Microwave electrosurgery procedure moving treatment of early-stage colon cancer from hospital theatres to endoscopy suites, significantly reducing treatment time and NHS cost (by over £5K/procedure). Contributed to Hancock lead authorship on invited paper (IEEE Microwave Magazine doi: 10.1109/MMM.2014.2377571) and resulted in wide international readership within IEEE-MTT and European Society of Gastrointestinal Endoscopy communities (over 100,000 members). Formed substantial part of technical/clinical due diligence of Dowgate Capital <Shane.DeBhrun-Smith@dowgate.co.uk> when Creo Medical was floated on London Stock Exchange in 2016. Stock value as of Dec 2020 £330m.
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
